Document is current
Any future updates will be listed below
-
Authors
Schmoeckel, Michael
Thielmann, Matthias
Vitanova, Keti
Eberle, Thomas
Marczin, Nandor
Hassan, Kambiz
Liebold, Andreas
Lindstedt, Sandra
Mächler, Georg
Matejic-Spasic, Marijana
Wendt, Daniel
Deliargyris, Efthymios N.
Storey, Robert F.
-
Funding
Funding for this research was provided by:
CytoSorbents Inc., Princeton, NJ, USA
- License Information
-
More Information
Article History
Received: 5 November 2024
Accepted: 26 December 2024
First Online: 20 January 2025
Declarations
:
: Michael Schmoeckel, Matthias Thielmann, Kambiz Hassan, Stephan Geidel, Sandra Lindstedt, received speaker honoraria and travel fees. Marijana Matejic-Spasic, Daniel Wendt are full-time employees of CytoSorbents Europe GmbH, Berlin, Germany, Efthymios Deliargyris is a full-time employee of CytoSorbents Inc., Princeton, NJ, USA. Robert Storey reports institutional research grants/support from Cytosorbents and AstraZeneca; and personal fees from Alfasigma, AstraZeneca, Boehringer Ingelheim/Lilly, Chiesi, Cytosorbents, Daiichi Sankyo, Idorsia, Novartis, Novo Nordisk, Pfizer, PhaseBio and Tabuk.
